Guidelines for genetic testing in prostate cancer: a scoping review.

ABSTRACT:

Background

Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relatives. There are various guidelines and consensus statements for genetic testing in prostate cancer. Our aim is to review genetic testing recommendations across current guidelines and consensus statements and the level of evidence supporting those recommendations.

Methods

A scoping review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping review (PRISMA-ScR) guidelines. Electronic database searches and manual searches of grey literature, including webs

SUBMITTER: Tuffaha H 

PROVIDER: S-EPMC11543603 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature